4.7 Article

Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase

期刊

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijantimicag.2013.12.001

关键词

Escherichia coli; Extended spectrum beta-lactamase; Fosfomycin; Cefoxitin

资金

  1. Institut National de la Sante et de la Recherche Medicale
  2. Direction Generale de l'Offre de Soins

向作者/读者索取更多资源

The efficacy of fosfomycin alone or combined with cefoxitin was investigated in vitro and in a murine model of urinary tract infection due to susceptible Escherichia coli CFT073-RR and its transconjugant CFT073-RR Tc (pbla(CTX-M-15)) harbouring a plasmid carrying the bla(CTX-M-15) gene. In vitro, the combination of cefoxitin and fosfomycin was synergistic and bactericidal and prevented the emergence of fosfomycin-resistant mutants of CFT073-RR and CFT073-RRTc (pbla(CTX-M-15)) that were selected with fosfomycin alone. In vivo, the combination conferred an advantage in terms of kidney sterilisation of mice infected with either strain compared with fosfomycin monotherapy. (C) 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Infectious Diseases

Experience abroad and participation in ESCMID educational activities: results from a survey among French infectious diseases specialists in training

G. Catho, N. Peiffer-Smadja, J. Gras, L. Osei, M. Le Marechal

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Letter Rheumatology

Coxiella burnetii endocarditis as a possible cause of ANCA-associated vasculitis

Valentin Lacombe, Martin Planchais, Charlotte Boud'Hors, Anne Croue, Clea Melenotte, Didier Raoult, Vincent Dubee, Yves-Marie Vandamme

RHEUMATOLOGY (2020)

Letter Immunology

Enterococcal Endocarditis: Relapses or Reinfections? Reply

Anne-Gaelle Leroy, Stephane Corvec, Pierre Danneels, Vincent Dubee, Marie Kempf, Delphine Boucher, Nahema Issa, Olivia Peuchant, Fabrice Camou, David Boutoille, Raphael Lecomte

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis

P. Le Turnier, M. Gregoire, G. Deslandes, K. Lakhal, C. Deschanvres, R. Lecomte, J-P Talarmin, V Dubee, R. Bellouard, D. Boutoille, A-G Leroy, B. J. Gaborit

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Letter Infectious Diseases

Utility of hyposmia and hypogeusia for the diagnosis of COVID-19

Francois Benezit, Paul Le Turnier, Charles Declerck, Cecile Paille, Matthieu Revest, Vincent Dubee, Pierre Tattevin

LANCET INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Bedside prediction of intradialytic hemodynamic instability in critically ill patients: the SOCRATE study

Naike Bige, Jean-Remi Lavillegrand, Julien Dang, Philippe Attias, Stephanie Deryckere, Jeremie Joffre, Vincent Dubee, Gabriel Preda, Guillaume Dumas, Geoffroy Hariri, Claire Pichereau, Jean-Luc Baudel, Bertrand Guidet, Eric Maury, Pierre-Yves Boelle, Hafid Ait-Oufella

ANNALS OF INTENSIVE CARE (2020)

Article Multidisciplinary Sciences

Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model

Rachel Chenouard, Rafael Mahieu, David Luque Paz, Estelle Marion, Matthieu Eveillard, Vincent Dubee

Summary: This study compared the effects of ceftriaxone and temocillin on the abundance of ESBL-producing E. coli in the feces of colonized mice. The results showed that ceftriaxone increased the abundance of third-generation-cephalosporin resistant E. coli in feces, while temocillin had no effect or temporarily decreased the number of resistant E. coli. Using temocillin may help prevent the expansion of ESBL-PE in previously colonized patients.

PLOS ONE (2021)

Article Medicine, General & Internal

Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission (POCUSCO): a study protocol of an international study

Francois Morin, Delphine Douillet, Jean-Francois Hamel, Josue Rakotonjanahary, Florence Dupriez, Dominique Savary, Christophe Aube, Jeremie Riou, Vincent Dubee, Pierre-Marie Roy

Summary: This study aims to assess non-critical COVID-19 patients with L-POCUS within 48 hours of admission to determine the severity of lung damage and follow WHO recommendations for treatment.

BMJ OPEN (2021)

Article Infectious Diseases

Infective endocarditis in pregnant women without intravenous drug use: a multicentre retrospective case series

Laura Escola-Verge, Pau Rello, Charles Declerck, Vincent Dubee, Frederic Rouleau, Xavier Duval, Gilbert Habib, Yoan Lavie-Badie, Guillaume Martin-Blondel, Lydie Porte, Kevin Bouiller, Francois Goehringer, Christine Selton-Suty, Cristiane da Cruz Lamas, Francisco Nacinovich, Nahema Issa, Clemence Richaud, Nadjib Hammoudi, Francisco Jose Barranco, Benito Almirante, Pierre Tattevin, Nuria Fernandez-Hidalgo

Summary: This study included 25 cases of infective endocarditis in pregnant women, showing that infective endocarditis in pregnant women is not uncommon. Strict medical surveillance involving a multidisciplinary team including obstetricians and neonatologists is required to manage these cases effectively.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Letter Immunology

Reply to Cuervo et al and Horinouchi et al

Pierre Danneels, Jean-Francois Hamel, Adrien Lemaignen, Vincent Cattoir, Vincent Dubee

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

Implementation of point-of-care ultrasonography in an infectious disease ward

Charles Declerck, Rafael Mahieu, Diane Sanderink, Marine de la Chapelle, Pierre Abgueguen, Yves-Marie Vandamme, Vincent Dubee

Summary: This study reports on the acquisition and daily use of an ultrasonography device in a French infectious diseases ward. The results demonstrate the widespread use of POCUS and its positive impact on medical imaging requests. These findings highlight the significant potential of POCUS in infectious diseases specialties.

INFECTIOUS DISEASES NOW (2022)

Letter Infectious Diseases

The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey

Kevin Bouiller, Gaud Catho, Marion Le Marechal, Julien Gras, Maxime Hentzien, Nathan Peiffer-Smadja, Simon Bessis, Mathieu Cabon, Vincent Dubee, Adrien Lemaignen, Michael Thy, Capucine Martins, Pauline Thill, Lindsay Osei

INFECTIOUS DISEASES NOW (2021)

Article Pharmacology & Pharmacy

Clinical and epidemiological characteristics of COVID-19

Rafael Mahieu, Vincent Dubee

ACTUALITES PHARMACEUTIQUES (2020)

Article Education & Educational Research

How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study

Nathan Peiffer-Smadja, Francois-Daniel Ardellier, Pauline Thill, Anne-Lise Beaumont, Gaud Catho, Lindsay Osei, Vincent Dubee, Alexandre Bleibtreu, Adrien Lemaignen, Michael Thy

BMC MEDICAL EDUCATION (2020)

Article Nutrition & Dietetics

Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study

Gaelle Annweiler, Mathieu Corvaisier, Jennifer Gautier, Vincent Dubee, Erick Legrand, Guillaume Sacco, Cedric Annweiler

NUTRIENTS (2020)

Review Infectious Diseases

Lenacapavir: A novel injectable HIV-1 capsid inhibitor

Allison M. Hitchcock, Wesley D. Kufel, Keri A. Mastro Dwyer, Eric F. Sidman

Summary: Lenacapavir is a novel HIV-1 treatment option for patients with multidrug-resistant (MDR) HIV-1 infection. It has a favorable pharmacokinetic profile and has shown good tolerability and efficacy in clinical trials.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)

Article Infectious Diseases

Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort

Roberta Gagliardini, Alessandro Tavelli, Stefano Rusconi, Sergio Lo Caputo, Vincenzo Spagnuolo, Maria Mercedes Santoro, Andrea Costantini, Alessandra Vergori, Franco Maggiolo, Andrea Giacomelli, Giulia Burastero, Giordano Madeddu, Eugenia Quiros Roldan, Antonella d'Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri

Summary: This study evaluated multiple treatment failures to modern antiretroviral therapy in HIV-infected individuals and found that approximately 4% of them were difficult to treat. The difficult to treat group, compared to the non-difficult to treat group, was characterized by older age, higher prevalence of AIDS, lower CD4+ cell count, and higher risk of treatment failure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)